Emerging studies suggest Retatrutide , a dual stimulator targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , may represent a notable step forward for weight loss . Preliminary clinical https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide